ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com



×ðÁú¿Ê±ÊÇÒ»¼ÒÌṩÕûÌ×ÁÙ´²Ç°Åú¼þÉêÇëͬʱÇкÏÖйúGLPºÍÃÀ¹úGLP±ê×¼µÄCRO¹«Ë¾¡£
Ò»¼ÒΪ¹ú¼ÊÌṩÁÙ´²Ç°¶¯ÎïÊÔÑéµÄCRO¹«Ë¾¡£
Ò»¼ÒÓëÍâÑó´óÐÍCRO¹«Ë¾£¨ÃÀ¹úMPI Research£©½¨ÉèÏàÖúµÄÁÙ´²Ç°CROºÏ×ʹ«Ë¾¡£
Ò»¼ÒÌṩ½á½á¹¹ÉúÎïѧ¼°»¯Ñ§ÉúÎïѧЧÀ͵ÄCRO¹«Ë¾¡£
Ò»¼ÒÌṩ½á¡±ÍâÑóÒ©Æó - CRO - º£ÄÚÒ©Æó¡°Èý·½ÏàÖúµÄCRO¹«Ë¾¡£
ͨ¹ýAAALACÈÏÖ¤Ö®Ò»£¬ÇкÏUS FDAºÍCFDAµÄGLP±ê×¼¡£
ÖйúGLPÈÏÖ¤¼°Öйú±¾ÍÁʵÏÖ¹ú¼Ê»¯¹«Ë¾Ö®Ò»¡£
ÓµÓÐרҵµÄÑз¢ÍŶӼ°Ê®ÓàÄêµÄÑз¢Íâ°üЧÀÍÂÄÀú¡£
ÁªÏµ×ðÁú¿Ê±
Email:Marketing@medicilon.com.cn
µç»°£º021-58591500
Nice Insight¡¯s Top Companies lists are comprised of the highest scoring companies, as rated by buyers of outsourced services, with respect to customer perception within each category. Customer perception describes how a current buyer or prospect rates a company based on the information they have been exposed to¡ªfrom marketing materials to word-of-mouth influence, as well as experience with the company. Nice Insight uses six key drivers of outsourcing¡ªquality, reliability, productivity, affordability, innovation and regulatory history¡ªto measure customer perception; the number listed is the average of the six individual scores, down to the decimal point.
CRO Preclinical£¨ÁÙ´²Ç°CRO¹«Ë¾ÅÅÃû£©
| Analytical Services£¨ÆÊÎöЧÀÍÐÐÒµCRO¹«Ë¾ÅÅÃû£© | Overall CP | |
|---|---|---|
| 1 | Eurofins Lancaster | 92.80% |
| 2 | Surpass | 90.00% |
| 3 | Huntingdon Life Sciences | 89.13% |
| 4 | Frontage | 88.33% |
| 5 | QPS | 87.17% |
| 6 | BASi | 87.00% |
| 6 | Sannova Analytical | 87.00% |
| 8 | Product Safety Labs | 86.00% |
| 9 | Algorithme | 85.50% |
| 10 | Covance | 85.40% |
| 10 | Quintiles | 85.40% |
| BioAnalytical Services£¨ÉúÎïÆÊÎöЧÀÍCRO¹«Ë¾ÅÅÃû£© | Overall CP | |
|---|---|---|
| 1 | Product Safety Labs | 93.37% |
| 2 | Ricerca | 92.83% |
| 3 | Covance | 90.57% |
| 4 | Frontage | 90.00% |
| 5 | Charles River | 89.53% |
| 6 | QPS | 89.33% |
| 7 | Eurofins Lancaster | 88.90% |
| 8 | Huntingdon Life Sciences | 88.33% |
| 9 | Worldwide Clinical Trials | 87.63% |
| 10 | Seventh Wave | 87.57% |
| 10 | Sannova Analytical | 87.57% |
| Toxicology£¨¶¾ÀíѧCRO¹«Ë¾ÅÅÃû£© | Overall CP | |
|---|---|---|
| 1 | Sannova Analytical | 88.33% |
| 2 | Huntingdon Life Sciences | 87.20% |
| 3 | BASi | 86.67% |
| 4 | Frontage | 85.73% |
| 5 | Toxikon | 85.53% |
| 6 | MicroConstants | 84.30% |
| 7 | BRI | 81.67% |
| 7 | SNBL | 81.67% |
| 9 | Product Safety Labs | 81.33% |
| 10 | QPS | 81.00% |
| Pharmacovigilance£¨Ò©ÎïÇå¾²ÐÔÆÀ¼ÛCRO¹«Ë¾ÅÅÃû£© | Overall CP | |
|---|---|---|
| 1 | Worldwide Clinical Trials | 90.00% |
| 2 | Quintiles | 87.50% |
| 3 | Huntingdon Life Sciences | 86.67% |
| 4 | MPI Research | 82.00% |
| 5 | Algorithme | 81.13% |
| 6 | Frontage | 81.11% |
| 6 | SNBL | 81.11% |
| 8 | Tandem Labs | 80.56% |
| 9 | QPS | 79.33% |
| 10 | Charles River | 78.06% |
| Analytical Services£¨ÆÊÎöЧÀÍ£© | Overall CP | |
|---|---|---|
| 1 | Eurofins Lancaster | 92.80% |
| 2 | Clinlogix | 89.63% |
| 3 | SGS | 89.20% |
| 4 | Frontage | 88.33% |
| 5 | QPS | 87.17% |
| 6 | Sannova Analytical | 87.00% |
| 7 | Chiltern | 86.70% |
| 8 | Parexel | 86.40% |
| 9 | PPD | 85.86% |
| 10 | Covance | 85.40% |
| 10 | Quintiles | 85.40% |
| BioAnalytical Services£¨ÉúÎïÆÊÎöЧÀÍCRO¹«Ë¾ÅÅÃû£© | Overall CP | |
|---|---|---|
| 1 | Covance | 90.56% |
| 2 | Frontage | 90.00% |
| 2 | SGS | 90.00% |
| 4 | Charles River | 89.53% |
| 5 | QPS | 89.33% |
| 6 | Eurofins Lancaster | 88.90% |
| 7 | Clinlogix | 88.33% |
| 8 | CNS | 88.00% |
| 9 | Worldwide Clinical Trials | 87.63% |
| 10 | Sannova Analytical | 87.56% |
| Clinical Monitoring£¨ÁÙ´²¼ì²â£© | Overall CP | |
|---|---|---|
| 1 | Clinlogix | 89.06% |
| 2 | Parexel | 86.67% |
| 3 | PRA | 86.33% |
| 4 | Celerion | 85.46% |
| 5 | Rho | 85.13% |
| 6 | Medsource | 84.83% |
| 7 | QPS | 84.33% |
| 8 | SynteractHCR | 84.03% |
| 9 | SNBL | 84.00% |
| 10 | Novotech | 83.83% |
| Clinical Research£¨ÁÙ´²Ñо¿£© | Overall CP | |
|---|---|---|
| 1 | INC Research | 93.33% |
| 2 | Parexel | 85.97% |
| 3 | Celerion | 85.83% |
| 4 | Intertek | 85.30% |
| 5 | Clinlogix | 84.90% |
| 6 | Vince & Associates | 83.30% |
| 7 | Bioskin | 83.00% |
| 8 | InnoPharma | 82.83% |
| 9 | SanaClis | 82.80% |
| 10 | SGS |
82.26% |
Ïà¹ØÐÂÎÅ